The federal government plans to give the exclusive license for a new liver cancer drug to a pharmaceutical company owned by Chinaâs 63rd-richest man, HuffPost has learned. The National Institutes of Health proposes to grant Salubris Biotherapeutics, Inc. exclusive worldwide rights to a portfolio of patents on antibody drugs used to treat liver cancer, according to a notice published Monday on the Federal Register.
Vitamin A deficiency is the leading cause of preventable childhood blindness and is critical to achieving Millennium Development Goal 4:2 to reduce child mortality.revalence of vitamin A deficiency. Vitamin A deficiency (VAD) is a lack of vitamin A in humans. It is common in poorer countries but rarely seen in more developed countries. Nyctalopia (night blindness) is one of the first signs of VAD.
A Vitamin A deficiency can lead to a thickening of the cornea and eventually even to blindness. Keratomalacia, a condition that comes from severe deficiency of vitamin A, is a condition that is bilateral, meaning it usually affects both eyes.